Cancer Nanotheranostics

After a quarter of century of express technological advances, research has publicized the convolution of cancer, a disease confidentially related to the dynamic transformation of the genome. It is here that Nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. Nanotechnology offers numerous tools to diagnose and treat cancer, such as new imaging agents, multifunctional devices capable of overcome biological barriers to deliver therapeutic agents directly to cells and tissues involved in cancer growth and metastasis, and devices capable of predicting molecular changes to prevent action against precancerous cells. Nanomaterials-based delivery systems in Theranostics (Diagnostics & Therapy) provide better penetration of therapeutic and diagnostic substances within the body at a reduced risk in comparison to conventional therapies. At the present time, there is a growing need to enhance the capability of theranostics procedures where nanomaterials-based sensors may provide for the simultaneous detection of several gene-associated conditions and nanodevices with the ability to monitor real-time drug action. These innovative multifunctional nanocarriers for cancer theranostics may allow the development of diagnostics systems such as colorimetric and immunoassays, and in therapy approaches through gene therapy, drug delivery and tumor targeting systems in cancer. 
 

Cancer is one of the leading causes of death in the world and remains a difficult disease to treat. Current problems associated with conventional cancer chemotherapies include insolubility of drugs in aqueous medium; delivery of sub-therapeutic doses to target cells; lack of bioavailability; and most importantly, non-specific toxicity to normal tissues. Recent contributions of nanotechnology research address possible solutions to these conundrums. Nevertheless, challenges remain with respect to delivery to specific sites, real time tracking of the delivery system, and control over the release system after the drug has been transported to the target site.

Nanomedical research on nanoparticles is exploring these issues and has already been showing potential solutions for cancer diagnosis and treatment. But a heterogeneous disease like cancer requires smart approaches where therapeutic and diagnostic platforms are integrated into a theranostic approach. Theranostics – a combination of the words therapeutics and diagnostics – describes a treatment platform that combines a diagnostic test with targeted therapy based on the test results, i.e. a step towards personalized medicine. Making use of nanotechnology materials and applications, theranostic nanomedicine can be understood as an integrated nanotherapeutic system, which can diagnose, deliver targeted therapy and monitor the response to therapy.

Theranostic nanomedicine has the potential for simultaneous and real time monitoring of drug delivery, trafficking of drug and therapeutic responses.

 

 

 

  • Cancer Microenvironment
  • Stealth Nanoparticles and Tumour Penetrating Peptides
  • Photothermal and Photodynamic therapies
  • Ferrofluid and magnetic hyperthermia
  • New Nanomaterials
  • Imaging and Cancer Theranostics
  • Advances in Nanotechnology for cancer treatment
  • Translational Nanomedicines
  • Cancer Diagnostics

Related Conference of Cancer Nanotheranostics

Dec 03-04, 2018

3rd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
March 5-7, 2018

20th Global Congress on Biotechnology

London, UK
May 09-10, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
June 04-06, 2018

12th Annual Conference on Stem Cell and Regenerative Medicine

Prague, Czech Republic
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
SEPTEMBER 24-25, 2018

5th World Congress on HUMAN GENETICS

BERLIN, GERMANY
September 17-18, 2018

International Podiatry Conference

Dubai, UAE
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 19th -20th, 2018

5th World Conference on Synthetic Biology and Gene Editing

Tokyo,Japan
September 20-21,2018

6th Annual Congress on Biology and Medicine of Molecules

Kuala Lumpur, Malaysia
September 20-21, 2018

Tissue Repair and Regeneration Congress

Dubai, UAE
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Disorders

Philadelphia, Pennsylvania, USA
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Boston, USA
October 25-26, 2018

International Conference on Human Genome Meeting

Istanbul, Turkey
November 2-3, 2018

International Congress & Expo on Genomics and Bioinformatics

Columbus, Ohio, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Stem Cell Research

Atlanta, Georgia, USA

Cancer Nanotheranostics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in